3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
4
Myelodysplastic Syndromes
3
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lymphoma
2
Leukemia
2
Hematologic Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Carcinoma in Situ
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Interventions
Metformin
2
semaglutide
1
maltodextrin
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Topiramate
1
Tirzepatide
1
Qsymia
1
Pulse Wave Analysis
1
Phentermine
1
Observation
1
Naltrexone
1
Liraglutide
1
Inositol
1
Glucagon-Like Peptide-1 Receptor
1
Exercise
1
Electrocardiography
1
Echocardiography
1
Diethylpropion
1
Diet, Reducing
1
Diet Therapy
1
Contraceptives, Oral
1
Caloric Restriction
1
Bupropion
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Electrocardiography
×
1 year
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled